🇺🇸 FDA
Patent

US 8338104

Method of diagnosing poor survival prognosis colon cancer using miR-103-2

granted A61PA61P1/04A61P35/00

Quick answer

US patent 8338104 (Method of diagnosing poor survival prognosis colon cancer using miR-103-2) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P35/00